The effect of basal-bolus therapy varies with baseline 1,5-anhydroglucitol level in people with Type 2 diabetes: a post hoc analysis.

Heller, S. orcid.org/0000-0002-2425-9565, Bowering, K., Raskin, P. et al. (4 more authors) (2018) The effect of basal-bolus therapy varies with baseline 1,5-anhydroglucitol level in people with Type 2 diabetes: a post hoc analysis. Diabetic Medicine , 35 (9). pp. 1273-1278. ISSN 0742-3071

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: @2018 The Authors. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
Dates:
  • Accepted: 23 May 2018
  • Published (online): 26 May 2018
  • Published: 7 August 2018
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Sheffield Teaching Hospitals
Depositing User: Symplectic Sheffield
Date Deposited: 28 Nov 2018 15:41
Last Modified: 28 Nov 2018 15:41
Published Version: https://doi.org/10.1111/dme.13693
Status: Published
Publisher: Wiley
Refereed: Yes
Identification Number: https://doi.org/10.1111/dme.13693
Related URLs:

Share / Export

Statistics